News
DNA’s chemical cousin, RNA, was the messenger that carries DNA instructions from the double helix in the cell’s nucleus to ...
9h
News-Medical.Net on MSNYale researchers uncover new RNA editing tools for safer genetic surgery
The ability to correct disease-causing genetic mistakes using genome editors holds great promise in medicine, but it is not ...
Sarepta is facing a number of issues currently, including platform-level safety concerns, management credibility issues, etc.
In 1957, just four years after Francis Crick and other scientists solved the riddle of DNA’s structure—the now famous double ...
1d
MedPage Today on MSNRNA-Targeted Drug Approved for Preventing Hereditary Angioedema Attacks
In June, the monoclonal antibody garadacimab (Andembry) was approved for prevention of HAE attacks at a dose of once monthly ...
The approval makes donidalorsen the only treatment in the US for hereditary angioedema that is an RNA-targeted prophylactic.
3don MSN
Unlocking a mechanism for longevity: Study identifies key to slowing aging via RNA regulation
As aging progresses, the quality of DNA and proteins inside cells declines, which is known to be the cause of various ...
Researchers at San Diego State University and Michigan State University are shedding new light on how viruses meticulously ...
Single-cell proteomics with RNA sequencing uncover hidden gene expression dynamics in stem cell differentiation.
DAWNZERA is the first and only RNA-targeted medicine approved for HAE, designed to target plasma prekallikrein (PKK), a key protein that activates inflammatory mediators associated with acute attacks ...
On Thursday, the U.S. Food and Drug Administration (FDA) approved Ionis Pharmaceuticals, Inc.’s (NASDAQ:IONS) Dawnzera ...
Waltham, Massachusetts–based Skyhawk Therapeutics has been collecting collaborations with larger companies in spades since ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results